Gentry Yurak, - Speech-Language Pathologist in Daphne, AL

Gentry Yurak, is a Speech-language Pathologist based in Daphne, Alabama. Gentry Yurak is licensed to practice in Alabama (license number 4507) and her current practice location is 26420 Kensington Pl Ste C, Daphne, Alabama. She can be reached at her office (for appointments etc.) via phone at (251) 517-0355.

NPI number for Gentry Yurak is 1285298331 and her current mailing address is 26420 Kensington Pl Ste C, Daphne, Alabama. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1285298331.

Contact Information

Gentry Yurak,
26420 Kensington Pl Ste C,
Daphne, AL 36526-5123
(251) 517-0355
Not Available



Healthcare Provider's Profile

Full NameGentry Yurak
GenderFemale
SpecialitySpeech-language Pathologist
Location26420 Kensington Pl Ste C, Daphne, Alabama
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1285298331
  • Provider Enumeration Date: 04/24/2019
  • Last Update Date: 04/24/2019

Medical Identifiers

Medical identifiers for Gentry Yurak such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1285298331NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 4507 (Alabama)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gentry Yurak is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gentry Yurak,
26420 Kensington Pl Ste C,
Daphne, AL 36526-5123

Ph: () -
Gentry Yurak,
26420 Kensington Pl Ste C,
Daphne, AL 36526-5123

Ph: (251) 517-0355

News Archive

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Protalex, Inc, a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and inflammatory diseases, today announced enrollment of the first patients in the 3rd cohort of its ongoing multicenter Phase 1b dose escalation clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA) being conducted in South Africa. The dose was increased by a factor of two from the 2nd cohort.

Is it safe for SARS-CoV-2 positive mothers to breastfeed?

Even as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to cause thousands of cases every day, with many deaths, life continues to move on regardless. Births occur as usual, and in many countries, mothers prefer to breastfeed their babies, at least for the first few months of life.

Insulin resistance occurs in the brains of people with Alzheimer's

Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells.

Patients worried about statin use after label warnings from FDA

The U.S. Food and Drug Administration's announcement Tuesday stated that it would require additional safety warnings on the labels of the cholesterol-lowering drugs. Doctors have said that while the benefits of statins outweigh their potential harm, some patients are alarmed by the new announcement.

Read more News

› Verified 8 days ago


Speech-Language Pathologist in Daphne, AL

Rachel Arzaga, M.S., CF-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 26420 Kensington Pl Ste C, Daphne, AL 36526
Phone: 251-517-0355    
Ms. Breanne Dutter Kirchler, M.S. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 101 Villa Dr, Daphne, AL 36526
Phone: 251-621-4200    
Whitney Smith, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 11626 Us Highway 90, Daphne, AL 36526
Phone: 601-573-9712    
Renee Stutes Howard, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 8909 Rand Ave, Daphne, AL 36526
Phone: 251-210-1632    
Ms. Shelley Tyrrell Scott, MS CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 11125 Pontchartrain Loop, Daphne, AL 36526
Phone: 251-626-2366    
Jubilee Speech Therapy Llc
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 12482 Cressida Loop, Daphne, AL 36526
Phone: 985-707-5599    
Mrs. Melanie Brady Waters, M.C.D., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 29000 Highway 98 Ste 202b, Daphne, AL 36526
Phone: 251-786-8255    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.